Bryan C. Fuchs

8.0k total citations · 1 hit paper
105 papers, 4.7k citations indexed

About

Bryan C. Fuchs is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Bryan C. Fuchs has authored 105 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 41 papers in Hepatology and 27 papers in Molecular Biology. Recurrent topics in Bryan C. Fuchs's work include Liver Disease Diagnosis and Treatment (35 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers) and Liver physiology and pathology (16 papers). Bryan C. Fuchs is often cited by papers focused on Liver Disease Diagnosis and Treatment (35 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers) and Liver physiology and pathology (16 papers). Bryan C. Fuchs collaborates with scholars based in United States, Japan and Germany. Bryan C. Fuchs's co-authors include Barrie P. Bode, Kenneth K. Tanabe, Peter Caravan, Michael Lanuti, Tsutomu Fujii, Raymond T. Chung, Jonathan M. Goodwin, Gregory Y. Lauwers, Suguru Yamada and Yujin Hoshida and has published in prestigious journals such as Journal of the American Chemical Society, JAMA and Journal of Clinical Investigation.

In The Last Decade

Bryan C. Fuchs

103 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime?

2005 568 citations Bryan C. Fuchs et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryan C. Fuchs United States	40	1.7k	1.4k	1.2k	1.0k	930	105	4.7k
Masashi Adachi Japan	45	4.1k 2.4×	980 0.7×	538 0.4×	2.8k 2.8×	982 1.1×	83	8.1k
Deepak Nagrath United States	35	3.2k 1.9×	414 0.3×	301 0.2×	1.0k 1.0×	2.1k 2.3×	70	5.2k
Jean L. Grem United States	41	1.8k 1.0×	892 0.7×	722 0.6×	3.0k 3.0×	539 0.6×	168	5.9k
Zhao–You Tang China	38	2.4k 1.4×	911 0.7×	2.0k 1.6×	1.5k 1.5×	1.8k 2.0×	164	5.7k
Yinkun Liu China	43	3.4k 2.0×	584 0.4×	743 0.6×	1.3k 1.3×	1.3k 1.4×	200	5.5k
Jin Ye United States	32	2.2k 1.2×	745 0.5×	478 0.4×	344 0.3×	547 0.6×	104	3.9k
Niramol Savaraj United States	47	3.2k 1.9×	579 0.4×	192 0.2×	2.4k 2.3×	1.7k 1.9×	211	6.9k
Ronnie T.P. Poon Hong Kong	42	1.6k 0.9×	1.8k 1.4×	3.4k 2.8×	1.5k 1.5×	1.3k 1.4×	89	6.1k
Anderson J. Ryan United Kingdom	42	3.9k 2.3×	522 0.4×	289 0.2×	2.9k 2.9×	1.5k 1.6×	159	7.4k
Fernando Vidal‐Vanaclocha Spain	34	1.6k 0.9×	290 0.2×	447 0.4×	965 0.9×	487 0.5×	72	3.1k

Countries citing papers authored by Bryan C. Fuchs

Since Specialization

Citations

This map shows the geographic impact of Bryan C. Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan C. Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan C. Fuchs more than expected).

Fields of papers citing papers by Bryan C. Fuchs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan C. Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan C. Fuchs. The network helps show where Bryan C. Fuchs may publish in the future.

Co-authorship network of co-authors of Bryan C. Fuchs

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan C. Fuchs. A scholar is included among the top collaborators of Bryan C. Fuchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan C. Fuchs. Bryan C. Fuchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Waghorn, Philip A., Ivy A. Rosales, Derek J. Erstad, et al.. (2023). Molecular MR Imaging of Renal Fibrogenesis in Mice. Journal of the American Society of Nephrology. 34(7). 1159–1165. 14 indexed citations

Shih, Amy Y., Romeo Papazyan, Peng Hsiao, et al.. (2023). pH Dependence of a GPR4 Selective Antagonist Hampers Its Therapeutic Potential. Journal of Pharmacology and Experimental Therapeutics. 386(1). 35–44. 5 indexed citations

Waghorn, Philip A., Diêgo S. Ferreira, Derek J. Erstad, et al.. (2021). Author Correction: Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis. Scientific Reports. 11(1). 18167–18167. 2 indexed citations

Zhou, Iris Y., Veronica Clavijo Jordan, Nicholas J. Rotile, et al.. (2020). Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis. Radiology. 296(1). 67–75. 27 indexed citations

Erstad, Derek J., Martin S. Taylor, Motaz Qadan, et al.. (2020). Platelet and neutrophil to lymphocyte ratios predict survival in patients with resectable colorectal liver metastases. The American Journal of Surgery. 220(6). 1579–1585. 20 indexed citations

Wang, Huan, Veronica Clavijo Jordan, Ian Ramsay, et al.. (2019). Molecular Magnetic Resonance Imaging Using a Redox-Active Iron Complex. Journal of the American Chemical Society. 141(14). 5916–5925. 108 indexed citations

Kim, Byeong–Moo, et al.. (2018). Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis. Scientific Reports. 8(1). 7499–7499. 40 indexed citations

Hirschfield, Hadassa, C. Billie Bian, Takaaki Higashi, et al.. (2018). In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment. Experimental & Molecular Medicine. 50(1). e419–e419. 40 indexed citations

Li, Shen, Sarani Ghoshal, Mozhdeh Sojoodi, et al.. (2018). Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis. Journal of Gastrointestinal Surgery. 23(1). 101–111. 36 indexed citations

10.

Désogère, Pauline, Luis F. Tapias, Tyson A. Rietz, et al.. (2017). Optimization of a Collagen-Targeted PET Probe for Molecular Imaging of Pulmonary Fibrosis. Journal of Nuclear Medicine. 58(12). 1991–1996. 47 indexed citations

11.

Kim, Rosa S., Daisuke Hasegawa, Nicolas Goossens, et al.. (2016). The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy. Scientific Reports. 6(1). 39342–39342. 74 indexed citations

12.

Tapias, Luis F., Sarah E. Gilpin, Xi Ren, et al.. (2015). Assessment of Proliferation and Cytotoxicity in a Biomimetic Three-Dimensional Model of Lung Cancer. The Annals of Thoracic Surgery. 100(2). 414–421. 21 indexed citations

13.

Mueller, Jessica L., Lindsay Y. King, Tian Gao, et al.. (2014). Poster Session 1: Viral Hepatitis and Liver Transplant. Hepatology. 60. 532A–545A.

14.

Fuchs, Bryan C., et al.. (2014). Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. Journal of Hepatology. 61(1). S79–S90. 167 indexed citations

15.

Caravan, Peter, Yan Yang, Anthony D. Schmitt, et al.. (2013). Molecular Magnetic Resonance Imaging of Pulmonary Fibrosis in Mice. American Journal of Respiratory Cell and Molecular Biology. 49(6). 1120–1126. 82 indexed citations

16.

Hernandez, Jonathan M., Abul Elahi, Charles W. Clark, et al.. (2013). miR-675 Mediates Downregulation of Twist1 and Rb in AFP-Secreting Hepatocellular Carcinoma. Annals of Surgical Oncology. 20(S3). 625–635. 67 indexed citations

17.

Goodwin, Jonathan M., Anthony D. Schmitt, Bryan C. Fuchs, et al.. (2012). Angiogenesis Inhibition Using an Oncolytic Herpes Simplex Virus Expressing Endostatin in a Murine Lung Cancer Model. Cancer Investigation. 30(3). 243–250. 20 indexed citations

18.

Fujii, Tsutomu, Bryan C. Fuchs, Gregory Y. Lauwers, et al.. (2008). Mouse model of CCl4-induced HCC: histopathological changes and expression of EGF and CD133. Cancer Research. 68. 2954–2954.

19.

Kulu, Yakup, Jon D. Dorfman, Darshini Kuruppu, et al.. (2008). Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice. Cancer Gene Therapy. 16(4). 291–297. 30 indexed citations

20.

Gabler, B., Bryan C. Fuchs, Wolfgang Herrmann, et al.. (2004). EGF supplement therapy with a controlled release device in patients with keratoconjunctivitis sicca seems to improve dry eye symptoms. Investigative Ophthalmology & Visual Science. 45(13). 3910–3910. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact